NSC |
Compound |
Enrichment |
Correlation |
NSC 670688 |
Null |
0.0016365323975257 |
0.49047017 |
NSC 688074 |
16,24-Cyclo-13,14-secoergost-2-ene-18,26-dioic acid, 5-chloro-14,17:14,27-diepoxy-6,13,20,22-tetrahydroxy-1,15-dioxo-, .gamma.-lactone .delta.-lactone |
0.00163653239752571 |
0.5981508 |
NSC 682836 |
Propanimidoyl chloride, N-[[[[2-(trifluoromethoxy)phenyl] amino]carbonyl]oxy]- |
0.00166185890990729 |
0.41718804 |
NSC 715522 |
Null |
0.00166185890990729 |
0.4018113 |
NSC 720340 |
Null |
0.00166185890990729 |
0.44724006 |
NSC 726718 |
3-(Benzothiazol-6-ylamino)-7-chloro-8-methyl-1,1,-dioxo-4H-1 ,5,2-benzodithiazepin-4-ylideneacetic acid |
0.00166185890990729 |
0.43628931 |
NSC 727985 |
NSC 708781 incorporated in micelles, 0.55% (w/w) of drug |
0.00166185890990729 |
0.41644644 |
NSC 293046 |
Carbamimidothioic acid, (4-oxo-2-phenyl-4H-1-benzopyran-8-yl)methyl ester, monohydrobromide |
0.00166561193816139 |
0.48166477 |
NSC 621968 |
Null |
0.00166561193816139 |
0.44170626 |
NSC 639503 |
Cyclopentanone, 2-hexylidene-5-[(4-morpholinyl)methyl]-, hydrochloride |
0.00166561193816139 |
0.60708428 |